Overexpression of Bcl-2 or Bcl-X(L) transgenes and photoreceptor degeneration

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 12, 1996, Pages 2434-2446

  Joseph, Robert M ^a   Li, Tiansen ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

apoptosis; bcl 2; bcl X(L); light damage; retinal degeneration

Indexed keywords

RHODOPSIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEGENERATION; DIAGNOSIS; GENE EXPRESSION REGULATION; GENE MUTATION; MICROPHOTOGRAPHY; MOUSE; NONHUMAN; ONCOGENE; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DEGENERATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL DEATH; CROSSES, GENETIC; DNA DAMAGE; DNA PRIMERS; ELECTRORETINOGRAPHY; FEMALE; LIGHT; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOTORECEPTORS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION INJURIES, EXPERIMENTAL; RETINA; RETINAL DEGENERATION; RHODOPSIN; RNA, MESSENGER; TRANSGENES;

EID: 0029801850     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Chang GQ, Hao Y, Wong F, Apoptosis: Final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron. 1993;11:595-605.
2. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci U S A. 1994; 91:974-978.
3. Lolley RN, Rong H, Craft CM. Linkage of photoreceptor degeneration by apoptosis with inherited defect in phototransduction. Invest Ophthalmol Vis Sci. 1994;35:358-362.
4. Smith S, Bora N, McCool D, et al. Photoreceptor cells in the vitiligo mouse die by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:2193-2201.
5. Wyllie A, Kerr J, Currie A. Cell death: The significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
6. Poblenz A, Singh S, Campbell M, Fox D. Apoptosis in retinas of developmentally dead-exposed rats produces 50-700 kbp, but not internucleosomal, DNA fragments. Invest Ophthalmol Vis Sci. 1995;36:S637.
7. Martin S, Green D. Protease activation during apoptosis: Death by a thousand cuts? Cell. 1995;82:349-352.
8. Earnshaw W. Apoptosis - Lessons from in vitro systems. Trends in Cell Biology. 1995;5:217-220.
9. Kumar S. Ice-like proteases in apoptosis. Trends Biochem Sci. 1995;20:198-202.
10. Vaux D, Cory S, Adams J. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335:440-442.
11. Cleary M, Smith D, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14; 18) translocation. Cell. 1986;47:19-28.
12. Tsujimoto Y, Croce C. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci U S A. 1986;83:5214-5218.
13. Hengartner M, Horvitz H. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 1994;76:665-676.
14. Reed JC. Bcl-2 and the regulation of programmed cell death [Review]. J Cell Biol. 1994;124:1-6.
15. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family [Review]. Annual Review of Immunology. 1995;13:513-543.
16. Dubois-Dauphin M, Frankowski H, Tsujimoto Y, Huarte J, Martinou JC. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc Natl Acad Sci U S A. 1994;91:3309-3313.
17. Martinou JC, Dubois-Dauphin M, Staple JK, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 1994;13:1017-1030.
18. Farlie PG, Dringen R, Rees SM, Kannourakis G, Bernard O. bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci U S A. 1995;92:4397-4401.
19. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer S. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A. 1991;88:6961-6965.
20. Lu Q-L, Poulsom R, Wong L, Hanby A. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol. 1993;169:431-437.
21. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ. bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development. 1994;120:301-311.
22. Chen S, Garey L, Jen L. Bcl-2 proto-oncogene protein immunoreactivity in normally developing and axotomised rat retinas. Neurosci Lett. 1994;172:11-14.
23. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597-608.
24. Gonzalezgarcia M, Garcia I, Ding LY, et al. Bcl-X is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A. 1995;92:4304-4308.
25. Hockenbery D, Oltvai Z, Yin X, Milliman C, Korsmeyer S. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241-251.
26. Kane DJ, Sarafian TA, Anton R, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 1993;262:1274-1277.
27. Muschel R, Bernhard E, Garza L, McKenna W, Koch C. Induction of apoptosis at different oxygen tensions: Evidence that oxygen radicals do not mediate apoptotic signaling. Cancer Res. 1995;55:995-998.
28. Vaux D, Aguila H, Weissman I. Bcl-2 prevents death of factor deprived cells but fails to prevent apoptosis in targets of cell-mediated killing. Int Immunol. 1992;4:821-824.
29. Itoh N, Tsujimoto Y, Nagata S. Effect of Bcl-2 on Fas antigen-mediated cell death. J Immunol. 1993;151: 621-627.
30. Cuende E, Ales-Martinez J-E, Ding L, Gonzalez-Garcia M, Nunez C-A, Nunez G. Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells. EMBO J. 1993;12:1555-1560.
31. Chiu V, Walsh C, Liu C, Reed J, Clark W. Bcl-2 blocks degranulation but not Fas-based cell-mediated cytotoxicity. J Immunol. 1995;154:2023-2032.
32. Olsson JE, Gordon JW, Pawlyk BS, et al. Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosa. Neuron. 1992;9:815-830.
33. Li T, Franson WK, Gordon JW, Berson EL, Dryja TP. Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration. Proc Natl Acad Sci U S A. 1995;92:3551-3555.
34. Nathans J, Hogness DS. Isolation and nucleotide sequence of the gene encoding human rhodopsin. Proc Natl Acad Sci U S A. 1984;81:4851-4855.
35. Pittler SJ, Baehr W. Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc Natl Acad Sci U S A. 1991;88:8322-8326.
36. LaVail M, Gorrin G, Repaci M, Thomas L, Ginsberg H. Genetic regulation of light damage to photoreceptors. Invest Ophthalmol Vis Sci. 1987;28:1043-1048.
37. Zhang D, Hardy M, Pecci-saavedar J, Homayoun P, Gordon W, Bazan N. Light induced cell death in in vitro retinas of the rat. Invest Ophthalmol Vis Sci. 1995; 36:S917.
38. Wald G, Brown P. The molar extinction of rhodopsin. J Gen Physiol. 1953;37:189-200.
39. Gavrieli Y, Sherman Y, Ben-Sasson S. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;19:493-501.
40. Bowes C, van Veen T, Farber DB. Opsin, G-protein and 48-kDa protein in normal and rd mouse retinas: Developmental expression of mRNAs and proteins and light/dark cycling of mRNAs. Exp Eye Res. 1988; 47:369-390.
41. Bowes C, Li T, Danciger M, Baxter LG, Applebury ML, Farber DB. Retinal degeneration in the rd mouse is caused by a defect in the β-subunit of rod cGMP-phosphodiesterase. Nature. 1990;347:677-680.
42. Janiak F, Leber B, Andrews DW. Assembly of Bcl-2 into microsomal and outer mitochondrial membranes. J Biol Chem. 1994;269:9842-9.
43. Noell W. Aspects of experimental and hereditary retinal degeneration. In: Gaymore C, ed. Biochemistry of the Retina. New York: Academic Press; 1965:51-72.
44. Williams T, Howell W. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci. 1983;24:285-287.
45. Organisciak D, Winkler B, eds. Retinal light damage: Practical and theoretical considerations. In: Osborne N, Chader G, eds. Progress in Retinal and Eye Research. Vol. 13. Oxford: Pergamon Press; 1994:1-29.
46. Wong P, Kutty RK, Darrow RM, et al. Changes in clusterin expression associated with light-induced retinal damage in rats. Biochem Cell Biol. 1994;72:499-503.
47. Wang M, Lam TT, Fu J, Tso MOM. Tempol, a superoxide dismutase mimic, ameliorates light-induced retinal degeneration. Res Commun Mol Pathol Pharmacol. 1995;89:291-305.
48. Flannery J, Chen J, Xu J, Simon M. Overexpression of Bcl-2 can interfere with apoptosis in retinal degeneration. Invest Ophthalmol Vis Sci. 1995;36:S615.
49. Fletcher RT, Sanyal S, Krishna G, Aguirre G, Chader GJ. Genetic expression of cyclic GMP phosphodiesterase activity defines abnormal photoreceptor differentiation in neurological mutants of inherited retinal degeneration. J Neurochem. 1986;46:1240-1245.
50. Oltvai Z, Milliman C, Korsmeyer S. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell. 1993;74:609-619.
51. Sedlak T, Oltvai Z, Yang E, et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci U S A. 1995;92:7834-7838.
52. Takayama S, Sato T, Krajewski S, et al. Cloning and functional analysis of BAG-1 : A novel Bcl-2-binding protein with anti-cell death activity. Cell. 1995;80:279-284.